Literature DB >> 8776604

Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC).

D P Kelsell1, J M Risk, I M Leigh, H P Stevens, A Ellis, H C Hennies, A Reis, J Weissenbach, D T Bishop, N K Spurr, J K Field.   

Abstract

Focal non-epidermolytic palmoplantar keratoderma (PPK or palmoplantar ectodermal dysplasia type III) is associated with oesophageal cancer in three families: two large pedigrees located in Liverpool, UK and in the midwestern American states and one smaller family from Germany. In these families, the PPK is inherited as autosomal dominant and has a late onset, usually manifesting between 7 and 8 years of age. The disease is characterised by thickening of the pressure areas of the soles, but is not restricted to the feet and also presents with oral leukokeratosis and follicular hyperkeratosis. The disease locus [previously termed the "tylosis oesophageal cancer gene' (TOC) locus] has been mapped to 17q23-qter by linkage analysis. This region is located telomeric to the keratin 16 gene, in which mutations have been identified in focal PPK families who show no increased cancer risk. We describe the close mapping of this locus to the interval between AFMb054zf9 and D17S1603 using haplotype analysis of additional Généthon markers in the region and show that although the American family is unlikely to be related to either of the other two, the UK and German pedigrees may share a common descent. This work provides a basis for positional cloning and candidate gene analysis in order to identify a gene that may be involved in familial oesophageal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8776604     DOI: 10.1093/hmg/5.6.857

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  Abnormalities of chromosome 17 in oesophageal cancer.

Authors:  Revendran Moodley; Anunathan Reddi; Runjan Chetty; Richard Naidoo
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

Review 2.  Screening for oesophageal cancer.

Authors:  Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Nat Rev Clin Oncol       Date:  2012-03-20       Impact factor: 66.675

3.  Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.

Authors:  Sho Nambara; Takaaki Masuda; Taro Tobo; Shinya Kidogami; Hisateru Komatsu; Keishi Sugimachi; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara; Koshi Mimori
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

4.  Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.

Authors:  Joanne E Langan; Charlotte G Cole; Elisabeth J Huckle; Shaun Byrne; Fiona E McRonald; Lynn Rowbottom; Anthony Ellis; Joan M Shaw; Irene M Leigh; David P Kelsell; Ian Dunham; John K Field; Janet M Risk
Journal:  Hum Genet       Date:  2004-03-09       Impact factor: 4.132

5.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

6.  Protection from intracellular oxidative stress by cytoglobin in normal and cancerous oesophageal cells.

Authors:  Fiona E McRonald; Janet M Risk; Nikolas J Hodges
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 7.  Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms.

Authors:  Anthony Ellis; Janet M Risk; Thiviyani Maruthappu; David P Kelsell
Journal:  Orphanet J Rare Dis       Date:  2015-09-29       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.